1. Cationic amphipathic peptide analogs of cathelicidin LL‐37 as a probe in the development of antimicrobial/anticancer agents
    Athanasios Tzitzilis et al, 2020, Journal of Peptide Science CrossRef
  2. The human cathelicidin peptide LL-37 inhibits pancreatic cancer growth by suppressing autophagy and reprogramming of the tumor immune microenvironment
    Zhu Zhang et al, 2022, Frontiers in Pharmacology CrossRef
  3. Translating Nanomedicine to Comparative Oncology—the Case for Combining Zinc Oxide Nanomaterials with Nucleic Acid Therapeutic and Protein Delivery for Treating Metastatic Cancer
    R.K. DeLong et al, 2019, Journal of Pharmacology and Experimental Therapeutics CrossRef
  4. Cathelicidin Antimicrobial Peptide Acts as a Tumor Suppressor in Hepatocellular Carcinoma
    Lien-Hung Huang et al, 2023, International Journal of Molecular Sciences CrossRef
  5. Detection of a MicroRNA molecular signature of ultraviolet radiation in the superficial regions of melanocytic nevi on sun-exposed skin
    Achim Bell et al, 2018, Modern Pathology CrossRef
  6. Why Be One Protein When You Can Affect Many? The Multiple Roles of YB-1 in Lung Cancer and Mesothelioma
    Thomas G. Johnson et al, 2019, Frontiers in Cell and Developmental Biology CrossRef
  7. A novel technique to diagnose non‐melanoma skin cancer by thermal conductivity measurements: Correlations with cancer stromal factors
    Taku Fujimura et al, 2019, Experimental Dermatology CrossRef
  8. Granzyme A Stimulates pDCs to Promote Adaptive Immunity via Induction of Type I IFN
    Kanako Shimizu et al, 2019, Frontiers in Immunology CrossRef
  9. YB-1 Is Altered in Pregnancy-Associated Disorders and Affects Trophoblast in Vitro Properties via Alternation of Multiple Molecular Traits
    Violeta Stojanovska et al, 2021, International Journal of Molecular Sciences CrossRef
  10. Peptides of the innate immunity as potential anticancer agents: pros and cons
    A. N. Chernov et al, 2021, Medical Immunology (Russia) CrossRef
  11. Antimicrobial peptides: mechanism of action, activity and clinical potential
    Qi-Yu Zhang et al, 2021, Military Medical Research CrossRef
  12. Antimicrobial Peptides and the Gastrointestinal Health of Weaned Piglets
    燕涛 陈, 2019, Asian Case Reports in Veterinary Medicine CrossRef
  13. Cathelicidin LL-37 promotes EMT, migration and metastasis of hepatocellular carcinoma cells in vitro and mouse model
    Huidan Zhang et al, 2023, Cell Adhesion & Migration CrossRef
  14. A comprehensive review of the functions of YB-1 in cancer stemness, metastasis and drug resistance
    Akram Alkrekshi et al, 2021, Cellular Signalling CrossRef
  15. YB-1 as an Oncoprotein: Functions, Regulation, Post-Translational Modifications, and Targeted Therapy
    Qiyan Yin et al, 2022, Cells CrossRef
  16. Anticancer Effect of Cathelicidin LL-37, Protegrin PG-1, Nerve Growth Factor NGF, and Temozolomide: Impact on the Mitochondrial Metabolism, Clonogenic Potential, and Migration of Human U251 Glioma Cells
    Alexandr N. Chernov et al, 2022, Molecules CrossRef
  17. LL-37 Might Promote Local Invasion of Melanoma by Activating Melanoma Cells and Tumor-Associated Macrophages
    Kentaro Ohuchi et al, 2023, Cancers CrossRef
  18. Antimicrobial Peptides as Potential Therapy for Gastrointestinal Cancers: Opportunities and Challenges
    Li Ma et al, 2018, Antimicrobial Peptides in Gastrointestinal Diseases CrossRef
  19. Antimicrobial Host Defence Peptides: Immunomodulatory Functions and Translational Prospects
    Anne M. van der Does et al, 2019, Antimicrobial Peptides CrossRef
  20. miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1
    Zhuojia Lin et al, 2018, Molecular Therapy - Nucleic Acids CrossRef